Brazil’s pharma market saw steady growth between 2005 and 2018. Revenues have more than tripled over those 13 years, ending 2018 with over USD 18 billion in revenues.
Brazil is gradually climbing the global pharma market rankings and is projected to leap ahead of Italy and France to hold the number 5 spot by 2023.
More than half of the top 20 pharma companies in Brazil are domestic, with Ache, EMS Farma, and Eurofarma taking the top three spots. Ranking is based on MAT December 2018.